Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding
about
The interferon response inhibits HIV particle production by induction of TRIM22BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells.Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescueA bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent mannerRoles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae.Budding of enveloped viruses from the plasma membrane.Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.Molecular determinants that regulate plasma membrane association of HIV-1 GagNuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particlesDirect measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopySupramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.The Ebola virus matrix protein deeply penetrates the plasma membrane: an important step in viral egress.Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-polMyristoylation of the RING finger Z protein is essential for arenavirus buddingInterrelationship between cytoplasmic retroviral Gag concentration and Gag-membrane association.Targeting human immunodeficiency virus type 1 assembly, maturation and budding.A time-of-drug addition approach to target identification of antiviral compounds.Role of RNA in facilitating Gag/Gag-Pol interaction.In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane associationSynchronized HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable Gag anchoring.Down-regulation of N-myristoyl transferase expression in human T-cell line CEM by human immunodeficiency virus type-1 infection.Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies.In vitro assembly of human immunodeficiency virus type 1 Gag protein.Bioorthogonal mimetics of palmitoyl-CoA and myristoyl-CoA and their subsequent isolation by click chemistry and characterization by mass spectrometry reveal novel acylated host-proteins modified by HIV-1 infection.A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycleDominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag.
P2860
Q21131598-37CE934B-0822-44B0-810A-123308AFD1E6Q24303633-BC4D127F-379A-4185-BE9F-6D3B66AD1976Q30477939-DDB6D6C5-1790-44D2-8DEB-EE7FD4A26C27Q33642818-D780E77D-4065-446A-B078-0C3136FB8482Q33653475-421C7D99-14F3-4CB3-9BDD-50728A5D5716Q33785351-5FF9FA94-9015-4740-8C3B-6B13063C56BFQ33785367-A6082526-5385-4815-8102-557203A5A41EQ33794223-F5396633-4E11-4CA9-9E47-7C9EF4D6141FQ33815436-BF88490E-69A5-498B-B9C2-F6FAB394AC08Q34030593-844E6211-62CA-4411-8AB2-EDB997816988Q34065642-77828196-4EEA-4E81-B0F4-ED27A0E47276Q34781698-591E770D-117C-4D15-B094-46215AEB8F15Q34978433-F21FA2BA-AF2A-4EA9-AC0A-FBA39B75C0D3Q35113734-C985BB33-0436-4A94-8C64-2F5863F8E71DQ35635000-018A19EF-2406-46DB-AB7B-D3C516DE19C3Q35826475-F12AD842-FB29-4B20-9622-09F0E8D9B83BQ36325523-86CB5AE9-D74C-479F-BED4-43575AD86BC3Q36485425-E16EB3E9-696E-474C-8D2A-8AF4957C2292Q36824510-D3130908-F6D0-474F-AC07-2DC0238C5B4AQ36942505-FF2428D5-01AA-405A-9D05-C2D54A652D0CQ37568060-C31450A1-65C3-446F-A061-DA2D6163615CQ37633410-5698C9DF-01B9-4FD8-AB04-B083C8F7CAFCQ37928913-30777613-E0ED-4C62-9174-CAFCC166BA60Q39531429-0C819528-E23C-450B-936C-AC99269568BCQ39683238-AFD98D0B-5D7D-4A44-8280-DA86B8A7E4C1Q39879873-DF130136-683F-4133-B6B9-F9B11661F322Q40011798-B9A5082D-2874-47B4-96EA-20FCD3B34AA9Q40175971-2B3377D7-B940-4481-9DF1-74A0350DB1AFQ40776235-952E08DB-E5BA-43B8-8981-95C98FF9FC54Q40883661-7A5AC624-158E-45AB-BA8C-9BC07385583CQ40928746-9A7FD0D7-C09E-4E77-9CE2-4117009AD017Q41284460-28063981-08FA-4241-89EC-8B808F6DADCEQ42546287-6752A4A3-3D43-4975-9494-F1CACB3853D9Q42688106-7BC2841B-124C-4F57-B461-5DBA382215A4
P2860
Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Complete inhibition of human i ...... inhibition of particle budding
@ast
Complete inhibition of human i ...... inhibition of particle budding
@en
Complete inhibition of human i ...... inhibition of particle budding
@nl
type
label
Complete inhibition of human i ...... inhibition of particle budding
@ast
Complete inhibition of human i ...... inhibition of particle budding
@en
Complete inhibition of human i ...... inhibition of particle budding
@nl
prefLabel
Complete inhibition of human i ...... inhibition of particle budding
@ast
Complete inhibition of human i ...... inhibition of particle budding
@en
Complete inhibition of human i ...... inhibition of particle budding
@nl
P2093
P356
P1476
Complete inhibition of human i ...... inhibition of particle budding
@en
P2093
Y Morikawa
P304
P356
10.1074/JBC.271.5.2868
P407
P577
1996-02-02T00:00:00Z